DEXCOM INC. DL-,001/ US2521311074 /
2024-05-10 8:00:14 AM | Chg. +0.68 | Volume | Bid9:59:59 PM | Ask9:59:59 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
118.58EUR | +0.58% | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 46.9 bill.EUR | - | - |
GlobeNewswire
04-08
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
01-31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.
GlobeNewswire
2021-12-06
Integrity Applications, Inc. Expands U.S. Operations with the hiring of James P. Thrower, PhD, as Vi...